Crossmark

High prevalence of persistent residual parasitemia on days 3 and 14 after artemether–lumefantrine or pyronaridine–artesunate treatment of uncomplicated Plasmodium falciparum malaria in Nigeria

Crossref DOI link: https://doi.org/10.1007/s00436-022-07753-8

Published Online: 2022-12-13

Published Print: 2023-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Funwei, Roland I.

Uyaiabasi, Gabriel N.

Hammed, Wasiu A.

Ojurongbe, Olusola

Walker, Oladapo

Falade, Catherine O.
License Information

Text and Data Mining valid from 2022-12-13

Version of Record valid from 2022-12-13
More Information

Article History

Received: 12 September 2022

Accepted: 2 December 2022

First Online: 13 December 2022

Declarations

:

: The authors declare no competing interests.

: Ethical approval was obtained from the University of Ibadan/University College Hospital Institutional Review Board (UI/UCH/IRB).

: Written informed consent was obtained from all parents/guardians before enrollment into the study. Participants were free to withdraw if they felt otherwise to continue with the study.

: Details of participants were not disclosed in the manuscript. Therefore, it can be published.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below